NUVL:NSD-Nuvalent Inc (USD)

COMMON STOCK | Other |

Last Closing

USD 90.34

Change

-0.65 (-0.71)%

Market Cap

USD 9.24M

Volume

0.49M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
WOOF Pet Acquisition LLC

-0.16 (-3.66%)

USD 7.56B
JSM Navient Corporation SR NT 6% 1..

+0.06 (+0.30%)

USD 5.42B
BHFAL Brighthouse Financial Inc

-0.15 (-0.60%)

USD 5.13B
RGC Regencell Bioscience Holdings ..

-0.03 (-0.47%)

USD 3.60B
OB Outbrain Inc

+0.18 (+3.52%)

USD 1.71B
RILYG B. Riley Financial Inc. 5.00% ..

-0.20 (-1.70%)

USD 0.54B
RILYZ B. Riley Financial Inc. 5.25% ..

-0.22 (-2.12%)

USD 0.54B
NEWTZ Newtek Business Services Corp...

N/A

USD 0.45B
NEWTI NewtekOne, Inc. 8.00% Fixed Ra..

N/A

USD 0.43B
GAINN Gladstone Investment Corporati..

-0.09 (-0.37%)

USD 0.39B

ETFs Containing NUVL

DWAS Invesco DWA SmallCap Mome.. 1.12 % 0.60 %

-0.99 (0%)

USD 0.97B
CHNA 0.00 % 0.62 %

N/A

N/A
CHNA 0.00 % 0.79 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.76% 91% A- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.76% 91% A- 75% C
Trailing 12 Months  
Capital Gain 53.12% 93% A 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 53.12% 93% A 82% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 80.24% 93% A 91% A-
Dividend Return 80.24% 93% A 91% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 92.64% 17% F 23% F
Risk Adjusted Return 86.62% 100% F 93% A
Market Capitalization 9.24M 24% F 12% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative Book Value

The company has negative book value.